Grosmannia sp. SMA-2010
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA169914 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Methanobacterium sp. SMA-27 Genome sequencing and assembly
| PRJNA243944 | ENA
Project description:Grosmannia clavigera Genome Resequencing
| PRJNA182051 | ENA
Project description:Expression profiling of Grosmannia clavigera (Gc) under various conditions
| PRJNA184372 | ENA
Project description:Micrococcus sp. MG-2010-D12 Genome sequencing
| PRJNA280803 | ENA
Project description:This project is a proteomic comparison of Hyphomicrobium sp. MC8b grown with dichloromethane or with methanol. The datasets were obtained using the annotated genome of Hyphomicrobium sp. MC8b.
2021-09-09 | PXD021817 | Pride
Project description:modENCODE_submission_3228 This submission comes from a modENCODE project of Michael Snyder. For full list of modENCODE projects, see http://www.genome.gov/26524648 Project Goal: We are identifying the DNA binding sites for 300 transcription factors in C. elegans. Each transcription factor gene is tagged with the same GFP fusion protein, permitting validation of the gene's correct spatio-temporal expression pattern in transgenic animals. Chromatin immunoprecipitation on each strain is peformed using an anti-GFP antibody, and any bound DNA is deep-sequenced using Solexa GA2 technology. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODEDataReleasePolicyFinal2008.pdf EXPERIMENT TYPE: CHIP-seq. BIOLOGICAL SOURCE: Strain: OP130(official name : OP130 genotype : unc119(ed3);wgIs130(sma-9::TY1 EGFP FLAG C;unc119) outcross : 3 mutagen : Bombard tags : GFP::3xFlag description : This strain's transgene was constructed by Mihail Sarov at the Max Planck Institute for Cell Biology in Tubiginen using Tony Hyman's recombineering pipeline. The resulting plasmid was used for biolistic transformation of an unc-119(ed3) strain. The SMA-9::EGFP fusion protein is expressed in the correct sma-9 spatio-temporal expression pattern. This strain was used for ChIP-seq experiments to map the in vivo binding sites for the SMA-9 transcription factor. made_by : S Kim ); Developmental Stage: L2; Genotype: unc119(ed3);wgIs130(sma-9::TY1 EGFP FLAG C;unc119); Sex: Hermaphrodite; EXPERIMENTAL FACTORS: Developmental Stage L2; Target gene sma-9; Strain OP130(official name : OP130 genotype : unc119(ed3);wgIs130(sma-9::TY1 EGFP FLAG C;unc119) outcross : 3 mutagen : Bombard tags : GFP::3xFlag description : This strain's transgene was constructed by Mihail Sarov at the Max Planck Institute for Cell Biology in Tubiginen using Tony Hyman's recombineering pipeline. The resulting plasmid was used for biolistic transformation of an unc-119(ed3) strain. The SMA-9::EGFP fusion protein is expressed in the correct sma-9 spatio-temporal expression pattern. This strain was used for ChIP-seq experiments to map the in vivo binding sites for the SMA-9 transcription factor. made_by : S Kim ); temp (temperature) 20 degree celsius
2013-07-11 | E-GEOD-48700 | biostudies-arrayexpress
Project description:Antisense oligonucleotide (ASO) nusinersen (Spinraza®) modulates the pre–mRNA splicing of the SMN2 gene, allowing rebalance of biologically active SMN. It is administered intrathecally via lumbar puncture after removing an equal amount of cerebrospinal fluid (CSF). Its effect was proven beneficial and approved since 2017 for SMA treatment. Since the direct effect of nusinersen on RNA metabolism, the aim of this project was to evaluate cell-free RNA (cfRNA) in CSF of SMA patients under ASOs treatment for biomarker discovery.
2023-07-03 | GSE221900 | GEO